- Research works
- 45 ▼ 31% vs 2013–17
- Citations
- 1.1k 24.3 per fractional work
- Top-10% rate
- 10.0% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: In Silico Toxicology (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.5×
- Immunology and Microbiology 4.5×
- Medicine 2.5×
- Chemical Engineering 2.1×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Agricultural and Biological Sciences 1.4×
- Environmental Science 1.0×
- Neuroscience 0.8×
- Decision Sciences 0.8×
- Engineering 0.6×
- Chemistry 0.6×
- Physics and Astronomy 0.4×
- Mathematics 0.4×
- Social Sciences 0.4×
- Psychology 0.3×
- Computer Science 0.3×
- Materials Science 0.2×
Which keywords describe research at In Silico Toxicology (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Machine Learning, BAP1 mutations, Malignant Pleural Mesothelioma, Pharmacokinetics, Medicinal Chemistry, Mortality and Molecular Docking.
- spirometry
- Scientific Computing
- Physician-Scientist
- COPD
- Mass Spectrometry
- Fibrosis
- TGF-ß
- Epithelial-Mesenchymal Transition
- Work-Related Exposure
- Occupational Asthma
- Particulate Matter
- Air Pollution
- Management
- Nanoparticles
- Diagnosis
- Virtual Screening
- Molecular Docking
- Pharmacokinetics
- Malignant Pleural Mesothelioma
- Immunotherapy
- Machine Learning
- BAP1 mutations
- Oxidative Stress
- Medicinal Chemistry
- Mortality
- Health Effects
- Cardiovascular Disease
- Data Analysis
- Environmental Risk Assessment
- Biomarkers
- Alzheimer's Disease
- Prevention Guidelines
- Risk Assessment
- Pharmacology
- Toxicity
- Idiopathic Pulmonary Fibrosis
- Neurodegenerative Diseases
- Medical Research
- Python
- Toxicology
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Machine Learning4▲ 4.6×7 topics
- Immunotherapy4▲ 12×7 topics
- BAP1 mutations3▲ 300×1 topic
- Malignant Pleural Mesothelioma3▲ 300×1 topic
- Oxidative Stress2▲ 3.1×10 topics
- Pharmacokinetics2▲ 20×5 topics
- Medicinal Chemistry2▲ 14×2 topics
- Molecular Docking2▲ 35×1 topic
- Mortality2▲ 10×4 topics
- Virtual Screening2▲ 71×1 topic
- Health Effects2▲ 7.6×4 topics
- Diagnosis2▲ 4.4×3 topics
- Cardiovascular Disease2▲ 3.9×5 topics
- Nanoparticles2▲ 3.2×5 topics
- Data Analysis2▲ 13×3 topics
- Management2▲ 5.2×3 topics
- Environmental Risk Assessment2▲ 38×2 topics
- Air Pollution2▲ 31×1 topic
- Biomarkers2▲ 5.8×5 topics
- Particulate Matter2▲ 32×1 topic
- Alzheimer's Disease1▲ 12×4 topics
- Occupational Asthma1▲ 202×1 topic
- Prevention Guidelines1▲ 32×2 topics
- Work-Related Exposure1▲ 202×1 topic
- Risk Assessment1▲ 4.8×4 topics
- Epithelial-Mesenchymal Transition1▲ 31×2 topics
- Pharmacology1▲ 8.3×4 topics
- TGF-ß1▲ 15×2 topics
- Toxicity1▲ 6.3×5 topics
- Fibrosis1▲ 13×1 topic
- Idiopathic Pulmonary Fibrosis1▲ 65×1 topic
- Mass Spectrometry1▲ 12×3 topics
- Neurodegenerative Diseases1▲ 11×2 topics
- COPD1▲ 35×1 topic
- Medical Research1▲ 77×1 topic
- Physician-Scientist1▲ 77×1 topic
- Python1▲ 109×1 topic
- Scientific Computing1▲ 109×1 topic
- Toxicology1▲ 11×3 topics
- spirometry1▲ 35×1 topic
Which research topics does In Silico Toxicology (Switzerland) publish most on?
By volume in 2022–2025: Chronic Obstructive Pulmonary Disease (COPD) Research, Nail Diseases and Treatments, Dermatology and Skin Diseases and Nicotinic Acetylcholine Receptors Study.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
- 2 Nail Diseases and Treatments Epidemiology 1 works
- 3 Dermatology and Skin Diseases Dermatology 1 works
- 4 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
- 5 Wound Healing and Treatments Rehabilitation 0 works
- 6 Social Media in Health Education Health 0 works
- 7 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 0 works
- 8 Mast cells and histamine Immunology 0 works
- 9 Milk Quality and Mastitis in Dairy Cows Agronomy and Crop Science 0 works
- 10 Nigella sativa pharmacological applications Complementary and alternative medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has In Silico Toxicology (Switzerland)'s research output changed?
Output in 2018–2022 was 31% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Basel
- University of Basel
- Novartis (Switzerland)
- University Hospital of Basel
- Roche (Switzerland)
- Swiss Tropical and Public Health Institute
- Multidisciplinary Digital Publishing Institute (Switzerland)
- University Children’s Hospital Basel
- Bank for International Settlements
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.